相关实验视频

Updated: May 7, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

透析剂和血梅罗胺度在连续腹膜内治疗方案中,在腹膜透析相关的腹膜炎期间

Thatsaphan Srithongkul¹, Sukit Raksasuk¹, Bulaporn Techajongnumchai¹

¹Division of Nephrology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

|January 6, 2025

概括

腹膜内皮质美罗因通过保持足够的透析度,有效地治疗腹膜透析相关的腹膜炎. 这项研究评估了腹膜炎患者的美罗胺水平,证实了其治疗潜力.

科学领域:

药理学药理学是指药理学的学科.
腎臟病學 (nephrology) 是一種醫學.
传染性疾病传染性疾病

背景情况:

甲内皮质 (IP) 梅洛被推用于由扩展光谱β-乳酸酶产生生物体引起的腹膜透析 (PD) 相关的腹膜炎.
有限的数据存在于PD患者IP美罗的药理学.

研究的目的:

检查与PD相关的周周炎患者在持续IP期间的梅罗胺水平的血和透析.
评估IP美罗在治疗PD相关腹膜炎中的疗效.

主要方法:

这是一项前性描述性研究,涉及5名患有PD相关腹膜炎的患者.
患者接受了IP美罗胺加载剂量 (500毫克),其次是125毫克/升,每天四次更换.
用高性能液态染色学在24小时内测量了血和透析剂美罗的度.

主要成果:

透析剂美罗的平均峰值水平为158.1 mg/L;平均峰值血水平为29.4 mg/L.
24小时内平均最低透析剂水平为32.6 mg/L,始终超过最低抑制度 (> 8 mg/L).
五分之四的患者对治疗有反应;由于真菌腹膜炎,一名患者经历了治疗失败.

结论:

每6小时服用500毫克IP美洛,然后每6小时服用125毫克/升,可确保足够的透析剂度.
这种疗法有效治疗由敏感生物引起的与PD相关的周周炎.

更多相关视频

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

相关概念视频

Dialysis

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...